Medical Journals

Puromycin-purified Rat Brain Microvascular Endothelial Cell Cultures Exhibit Improved Barrier Properties in Response to Glucocorticoid Induction.

Authors:
  • Calabria Anthony R
  • Weidenfeller Christian
  • Jones Angela R
  • de Vries Helga E
  • Shusta Eric V

From: Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.

Journal of neurochemistry

  • Publish Date: May 2006
  • ISSN: 0022-3042
  • Volume: 97
  • Issue: 4
  • Pages: 922-33
  • Medium: Print
  • Language: English
  • Citation (JAMA): Calabria Anthony R, Weidenfeller Christian, Jones Angela R, et al. Puromycin-purified Rat Brain Microvascular Endothelial Cell Cultures Exhibit Improved Barrier Properties in Response to Glucocorticoid Induction.. J. Neurochem. May 2006;97:922-33

Abstract

In vitro blood-brain barrier (BBB) models using primary rat brain microvessel endothelial cells (BMEC) are often hampered by a lack of culture purity and poor barrier properties. To address these problems, the translation inhibitor puromycin was used to purify rat BMEC cultures. BMEC purities of 99.8% were routinely attained using puromycin treatment, and this technique proved to be far superior to other purification methods of similar difficulty. In contrast to cultures without puromycin treatment, purity of puromycin-treated cultures was unaffected by initial seeding density. Next, rat BMEC monolayer transendothelial electrical resistance (TEER) was increased by glucocorticoid treatment with either corticosterone (CORT) or hydrocortisone (HC), and a corresponding decrease in monolayer permeability to small molecules was observed. Importantly, cultures treated with both puromycin and glucocorticoid attained significantly higher TEER values (CORT 168 +/- 13 Omega x cm2; HC 218 +/- 66 Omega x cm2) than those treated by the glucocorticoid alone (CORT 57 +/- 5 Omega x cm2; HC 70 +/- 2 Omega x cm2). Glucocorticoid induction resulted in BMEC morphological changes that accompanied the increases in TEER, and BMEC tight junctions exhibited improved integrity as visualized by the localization of tight junction proteins zonula occluden-1, occludin and claudin-5. The combined use of puromycin and glucocorticoid therefore provides an in vitro system that is well suited for molecular level BBB investigations.

Mesh Headings (Keywords): Animals, Blood-Brain Barrier, Brain, Cell Culture Techniques, Cell Separation, Cells, Cultured, Electric Impedance, Endothelial Cells, Glucocorticoids, Membrane Proteins, Microcirculation, Models, Biological, Protein Synthesis Inhibitors, Puromycin, Rats, Tight Junctions


Check for Full Text / PubMed Unique Identifier (PMID): 16573646


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.